FDMT
Price
$4.37
Change
+$0.11 (+2.58%)
Updated
Jul 17, 04:59 PM (EDT)
Capitalization
201.98M
20 days until earnings call
RGNX
Price
$8.69
Change
+$0.19 (+2.24%)
Updated
Jul 17 closing price
Capitalization
437.88M
12 days until earnings call
Interact to see
Advertisement

FDMT vs RGNX

Header iconFDMT vs RGNX Comparison
Open Charts FDMT vs RGNXBanner chart's image
4D Molecular Therapeutics
Price$4.37
Change+$0.11 (+2.58%)
Volume$1.15K
Capitalization201.98M
REGENXBIO
Price$8.69
Change+$0.19 (+2.24%)
Volume$512.07K
Capitalization437.88M
FDMT vs RGNX Comparison Chart in %
Loading...
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
FDMT vs. RGNX commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMT is a Hold and RGNX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (FDMT: $4.36 vs. RGNX: $8.69)
Brand notoriety: FDMT and RGNX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FDMT: 64% vs. RGNX: 53%
Market capitalization -- FDMT: $201.98M vs. RGNX: $437.88M
FDMT [@Biotechnology] is valued at $201.98M. RGNX’s [@Biotechnology] market capitalization is $437.88M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMT’s FA Score shows that 0 FA rating(s) are green whileRGNX’s FA Score has 1 green FA rating(s).

  • FDMT’s FA Score: 0 green, 5 red.
  • RGNX’s FA Score: 1 green, 4 red.
According to our system of comparison, RGNX is a better buy in the long-term than FDMT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FDMT’s TA Score shows that 4 TA indicator(s) are bullish while RGNX’s TA Score has 4 bullish TA indicator(s).

  • FDMT’s TA Score: 4 bullish, 2 bearish.
  • RGNX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, FDMT is a better buy in the short-term than RGNX.

Price Growth

FDMT (@Biotechnology) experienced а +0.23% price change this week, while RGNX (@Biotechnology) price change was -4.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.06%. For the same industry, the average monthly price growth was +13.62%, and the average quarterly price growth was +40.41%.

Reported Earning Dates

FDMT is expected to report earnings on Nov 05, 2025.

RGNX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.06% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGNX($438M) has a higher market cap than FDMT($202M). RGNX YTD gains are higher at: 12.419 vs. FDMT (-21.724). RGNX has higher annual earnings (EBITDA): -122.44M vs. FDMT (-196.46M). FDMT has more cash in the bank: 321M vs. RGNX (268M). FDMT has less debt than RGNX: FDMT (23.9M) vs RGNX (79.8M). RGNX has higher revenues than FDMT: RGNX (157M) vs FDMT (23K).
FDMTRGNXFDMT / RGNX
Capitalization202M438M46%
EBITDA-196.46M-122.44M160%
Gain YTD-21.72412.419-175%
P/E RatioN/AN/A-
Revenue23K157M0%
Total Cash321M268M120%
Total Debt23.9M79.8M30%
FUNDAMENTALS RATINGS
RGNX: Fundamental Ratings
RGNX
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
21
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FDMTRGNX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
87%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
76%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
FDMT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HDRSF0.090.01
+6.08%
Highland Copper Company Inc.
BQSSF2.560.11
+4.49%
Boss Energy Ltd
CKHUF6.220.26
+4.36%
CK Hutchison Holdings LTD
IESFY119.43N/A
N/A
Interconexion Electrica S.A. E.S.P. - ISA
NLGCF0.10N/A
N/A
Northern Lion Gold Corp.

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with IDYA. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
+2.35%
IDYA - FDMT
45%
Loosely correlated
-0.27%
CCCC - FDMT
42%
Loosely correlated
+7.92%
BEAM - FDMT
42%
Loosely correlated
+1.89%
RGNX - FDMT
42%
Loosely correlated
+2.24%
STOK - FDMT
42%
Loosely correlated
+3.78%
More